These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26119569)

  • 1. Cost-Effectiveness Analysis of a Capitated Patient Navigation Program for Medicare Beneficiaries with Lung Cancer.
    Shih YC; Chien CR; Moguel R; Hernandez M; Hajek RA; Jones LA
    Health Serv Res; 2016 Apr; 51(2):746-67. PubMed ID: 26119569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.
    Sherman SK; Lange JJ; Dahdaleh FS; Rajeev R; Gamblin TC; Polite BN; Turaga KK
    JAMA Oncol; 2019 Feb; 5(2):236-242. PubMed ID: 30489611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer.
    Ito K; Elkin E; Blinder V; Keating N; Choudhry N
    Cancer; 2013 Jul; 119(13):2494-502. PubMed ID: 23775433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-Line Durvalumab in Addition to Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer: A U.S.-Based Cost-Effectiveness Analysis.
    Lin S; Luo S; Gu D; Li M; Rao X; Wang C; Huang P; Xu X; Weng X
    Oncologist; 2021 Nov; 26(11):e2013-e2020. PubMed ID: 34431578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of a patient navigation program to improve cervical cancer screening.
    Li Y; Carlson E; Villarreal R; Meraz L; Pagán JA
    Am J Manag Care; 2017 Jul; 23(7):429-434. PubMed ID: 28817782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of 3D image-guided brachytherapy compared with 2D brachytherapy in the treatment of locally advanced cervical cancer.
    Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
    Brachytherapy; 2015; 14(1):29-36. PubMed ID: 25443528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.
    Rosen AB; Hamel MB; Weinstein MC; Cutler DM; Fendrick AM; Vijan S
    Ann Intern Med; 2005 Jul; 143(2):89-99. PubMed ID: 16027450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.
    Ting J; Tien Ho P; Xiang P; Sugay A; Abdel-Sattar M; Wilson L
    Value Health; 2015 Sep; 18(6):774-82. PubMed ID: 26409604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necitumumab in Metastatic Squamous Cell Lung Cancer: Establishing a Value-Based Cost.
    Goldstein DA; Chen Q; Ayer T; Howard DH; Lipscomb J; Ramalingam SS; Khuri FR; Flowers CR
    JAMA Oncol; 2015 Dec; 1(9):1293-300. PubMed ID: 26313558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.
    Lin E; Chertow GM; Yan B; Malcolm E; Goldhaber-Fiebert JD
    PLoS Med; 2018 Mar; 15(3):e1002532. PubMed ID: 29584720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment.
    Kaplan RI; De Moraes CG; Cioffi GA; Al-Aswad LA; Blumberg DM
    JAMA Ophthalmol; 2015 May; 133(5):560-7. PubMed ID: 25741886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of ceritinib in previously untreated anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer in the United States.
    Zhou ZY; Mutebi A; Han S; Bensimon AG; Louise Ricculli M; Xie J; Dalal A; Culver K
    J Med Econ; 2018 Jun; 21(6):577-586. PubMed ID: 29458286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
    Lam SW; Wai M; Lau JE; McNamara M; Earl M; Udeh B
    Pharmacotherapy; 2017 Jan; 37(1):94-103. PubMed ID: 27870079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.
    Allaire BT; Ekweme D; Hoerger TJ; DeGroff A; Rim SH; Subramanian S; Miller JW
    Cancer Causes Control; 2019 Sep; 30(9):923-929. PubMed ID: 31297693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China.
    Wu B; Chen H; Shen J; Ye M
    Clin Ther; 2011 Oct; 33(10):1446-55. PubMed ID: 21992806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer.
    Tumeh JW; Shenoy PJ; Moore SG; Kauh J; Flowers C
    Am J Clin Oncol; 2009 Feb; 32(1):49-55. PubMed ID: 19194125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of a low-fat diet in the prevention of breast and ovarian cancer.
    Bós AM; Howard BV; Beresford SA; Urban N; Tinker LF; Waters H; Bós AJ; Chlebowski R; Ennis JM
    J Am Diet Assoc; 2011 Jan; 111(1):56-66. PubMed ID: 21185966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke: an Australian payer perspective.
    Arora N; Makino K; Tilden D; Lobotesis K; Mitchell P; Gillespie J
    J Med Econ; 2018 Aug; 21(8):799-809. PubMed ID: 29741126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC).
    Panje CM; Dedes KJ; Matter-Walstra K; Schwenkglenks M; Gautschi O; Siano M; Aebersold DM; Plasswilm L; Lupatsch JE;
    Radiother Oncol; 2018 Nov; 129(2):257-263. PubMed ID: 30104008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.